This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
World Health Organization. Coronavirus Disease (COVID-19) Dashboard [Internet]. Geneva: WHO; 2020 [updated 2021 Dec 02; cited 2021 Dec 03]. Available from: https://covid19.who.int.World Health OrganizationGenevaWHO2020[updated 2021 Dec 02; cited 2021 Dec 03]. Available from: https://covid19.who.int.Search in Google Scholar
European Centre for Disease Prevention and Control. Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA. Stockholm: ECDC; 2020. 26 p.European Centre for Disease Prevention and ControlStockholmECDC202026 p.10.2807/1560-7917.ES.2021.26.3.2101211Search in Google Scholar
Centers for Disease Control and Prevention. Science brief: Emerging SARS-CoV-2 variants [Internet]. USA: CDC; 2020 [updated 2021 Jan 28; cited 2021 Jul 30]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html.Centers for Disease Control and PreventionUSACDC2020[updated 2021 Jan 28; cited 2021 Jul 30]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html.Search in Google Scholar
Dawood AA. Mutated COVID-19 may foretell a great risk for mankind in the future. NMNI 2020;35:100673; DOI:10.1016/j.nmni.2020.100673.DawoodAAMutated COVID-19 may foretell a great risk for mankind in the future202035100673;10.1016/j.nmni.2020.100673Open DOISearch in Google Scholar
Maison DP, Ching LL, Shikuma CM, Nerurkar VR. Genetic characteristics and phylogeny of 969-bp S gene sequence of SARS-CoV-2 from Hawai’i Reveals the worldwide emerging P681H mutation. Hawaii J Health Soc Welf. 2021;80(3):52–61.MaisonDPChingLLShikumaCMNerurkarVRGenetic characteristics and phylogeny of 969-bp S gene sequence of SARS-CoV-2 from Hawai’i Reveals the worldwide emerging P681H mutation20218035261Search in Google Scholar
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.HuangCWangYLiXRenLZhaoJHuYZhangLFanGXuJGuXChengZYuTXiaJWeiYWuWXieXYinWLiHLiuMXiaoYGaoHGuoLXieJWangGJiangRGaoZJinQWangJCaoBClinical features of patients infected with 2019 novel coronavirus in Wuhan, China20203951022349750610.1016/S0140-6736(20)30183-5Open DOISearch in Google Scholar
Khateeb J, Li Y, Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care. 2021;25:244; DOI:10.1186/s13054-021-03662-x.KhateebJLiYZhangHEmerging SARS-CoV-2 variants of concern and potential intervention approaches20212524410.1186/s13054-021-03662-x827496234253247Open DOISearch in Google Scholar
Latif AA, Mullen JL, Alkuzweny M, Tsueng G, Cano M, Haag E, Zhou J, Zeller M, Hufbauer E, Matteson N, Wu C, Andersen KG, Su AI, Gangavarapu K, Hughes LD. B.1.351 Lineage Report. [Internet]. USA: outbreak. info; 2021 [updated 2021 Nov 30; cited 2021 Dec 03]. Available from: https://outbreak.info/situation-reports?pango=B.1.351.LatifAAMullenJLAlkuzwenyMTsuengGCanoMHaagEZhouJZellerMHufbauerEMattesonNWuCAndersenKGSuAIGangavarapuKHughesLDUSAoutbreak.info2021[updated 2021 Nov 30; cited 2021 Dec 03]. Available from: https://outbreak.info/situation-reports?pango=B.1.351.Search in Google Scholar
Di Giacomo S, Mercatelli D, Rakhimov A, Giorgi FM. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K. J. Med Virol. 2021;93:5638–5643; DOI:10.1002/jmv.27062.Di GiacomoSMercatelliDRakhimovAGiorgiFMPreliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K2021935638564310.1002/jmv.27062824237533951211Open DOISearch in Google Scholar
Fatoki TH, Ibraheem O, Ogunyemi IO, Akinmoladun AC, Ugboko HU, Adeseko CJ, Awofisayo OA, Olusegun SJ, Enibukun JM. Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants. J Biomol Struct Dyn. 2021;39(16):6195–6217; DOI:10.1080/07391102.2020.1794971.FatokiTHIbraheemOOgunyemiIOAkinmoladunACUgbokoHUAdesekoCJAwofisayoOAOlusegunSJEnibukunJMNetwork analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants202139166195621710.1080/07391102.2020.179497132686993Open DOISearch in Google Scholar
Hossain MU, Bhattacharjee A, Emon MTH, Chowdhury ZM, Ahammad I, Mosaib MG, Moniruzzaman M, Rahman MH, Islam MN, Ahmed I, Amin MR, Rashed A, Das KC, Keya CA, Salimullah M. Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics. J Genet Eng Biotechnol. 2021;19(1):52; DOI:10.1186/s43141-021-00152-z.HossainMUBhattacharjeeAEmonMTHChowdhuryZMAhammadIMosaibMGMoniruzzamanMRahmanMHIslamMNAhmedIAminMRRashedADasKCKeyaCASalimullahMNovel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics20211915210.1186/s43141-021-00152-z801789933797663Open DOISearch in Google Scholar
Rezaei S, Sefidbakht Y, Uskoković V. Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity. J Biomol Struct Dyn. 2020:1–20; DOI:10.1080/07391102.2020.1860829.RezaeiSSefidbakhtYUskokovićVComparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity202012010.1080/07391102.2020.1860829778483933331243Open DOISearch in Google Scholar
Kuriata A, Gierut AM, Oleniecki T, Ciemny MP, Kolinski A, Kurcinski M, Kmiecik S. CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures. Nucleic Acids Res. 2018;46(W1):W338–W343; DOI:10.1093/nar/gky356.KuriataAGierutAMOlenieckiTCiemnyMPKolinskiAKurcinskiMKmiecikSCABS-flex 2.0: a web server for fast simulations of flexibility of protein structures201846W1W338W34310.1093/nar/gky356603100029762700Open DOISearch in Google Scholar
Ikram A, Naz A, Awan FM, Rauff B, Obaid A, Hakim MS, Malik A, The impact of mutations on the structural and functional properties of SARS-CoV-2 proteins: A comprehensive bioinformatics analysis. bioRxiv [Preprint] 2021; DOI:10.1101/2021.03.01.433340.IkramANazAAwanFMRauffBObaidAHakimMSMalikAThe impact of mutations on the structural and functional properties of SARS-CoV-2 proteins: A comprehensive bioinformatics analysis[Preprint]202110.1101/2021.03.01.433340Open DOISearch in Google Scholar
Holm L. Using Dali for Protein Structure Comparison. Methods Mol Biol. 2020;2112:29–42; DOI:10.1007/978-1-0716-0270-6_3.HolmLUsing Dali for Protein Structure Comparison20202112294210.1007/978-1-0716-0270-6_332006276Open DOISearch in Google Scholar
Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, Wang Y and Guo X, Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020;12:244; DOI:10.3390/v12020244.XuJZhaoSTengTAbdallaAEZhuWXieLWangYGuoXSystematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV20201224410.3390/v12020244707719132098422Open DOISearch in Google Scholar
Tchesnokova V, Kulasekara H, Larson L, Bowers V, Rechkina E, Kisiela D, Sledneva Y, Choudhury D, Maslova I, Deng K, Kutumbaka K, Geng H, Fowler C, Greene D, Ralston J, Samadpour M, Sokurenko E. Acquisition of the L452R mutation in the ACE2-binding interface of spike protein triggers recent massive expansion of SARS-CoV-2 variants. J Clin Microbiol. 2021;59(11):e0092121; DOI:10.1128/JCM.00921-21.TchesnokovaVKulasekaraHLarsonLBowersVRechkinaEKisielaDSlednevaYChoudhuryDMaslovaIDengKKutumbakaKGengHFowlerCGreeneDRalstonJSamadpourMSokurenkoEAcquisition of the L452R mutation in the ACE2-binding interface of spike protein triggers recent massive expansion of SARS-CoV-2 variants20215911e009212110.1128/JCM.00921-21852557534379531Open DOISearch in Google Scholar
Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, Reichmuth ML, Bowen JE, Walls AC, Corti D, Bloom JD, Veesler D, Mateo D, Hernando A, Comas I, González-Candelas F; SeqCOVID-SPAIN consortium, Stadler T, Neher RA. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature, 2021;595(7869):707–712; DOI:10.1038/s41586-021-03677-y.HodcroftEBZuberMNadeauSVaughanTGCrawfordKHDAlthausCLReichmuthMLBowenJEWallsACCortiDBloomJDVeeslerDMateoDHernandoAComasIGonzález-CandelasFSeqCOVID-SPAIN consortiumStadlerTNeherRASpread of a SARS-CoV-2 variant through Europe in the summer of 20202021595786970771210.1038/s41586-021-03677-y34098568Open DOISearch in Google Scholar
Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, Storici P, Masciovecchio C, Angeletti S, Ciccozzi M, Gallo RC, Zella D, Ippodrino R. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. J Transl Med. 2020;18(1):179; DOI:10.1186/s12967-020-02344-6.PachettiMMariniBBenedettiFGiudiciFMauroEStoriciPMasciovecchioCAngelettiSCiccozziMGalloRCZellaDIppodrinoREmerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant202018117910.1186/s12967-020-02344-6717492232321524Open DOISearch in Google Scholar
Adeoye AO, Oso BJ, Olaoye IF, Tijjani H, Adebayo AI. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. J Biomol Struct Dyn. 2021;39(10):3469–3479; DOI:10.1080/07391102.2020.1765876.AdeoyeAOOsoBJOlaoyeIFTijjaniHAdebayoAIRepurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus202139103469347910.1080/07391102.2020.1765876723288732375574Open DOISearch in Google Scholar
Centers for Disease and Control Prevention. SARS-CoV-2 Variant Classifications and Definitions [Internet]. USA: CDC; 2020 [updated 2021 Dec 01; cited 2021 Dec 03]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.Centers for Disease and Control PreventionUSACDC2020[updated 2021 Dec 01; cited 2021 Dec 03]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.Search in Google Scholar
Schmidt F, Weisblum Y, Rutkowska M, Poston D, Da Silva J, Zhang F, Bednarski E, Cho A, Schaefer-Babajew DJ, Gaebler C, Caskey M, Nussenzweig MC, Hatziioannou T, Bieniasz PD. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature. 2021:1–9; DOI:10.1038/s41586-021-04005-0.SchmidtFWeisblumYRutkowskaMPostonDDa SilvaJZhangFBednarskiEChoASchaefer-BabajewDJGaeblerCCaskeyMNussenzweigMCHatziioannouTBieniaszPDHigh genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape20211910.1038/s41586-021-04005-034544114Open DOISearch in Google Scholar
Janik E, Niemcewicz M, Podogrocki M, Majsterek I, Bijak M. The emerging concern and interest SARS-CoV-2 variants. Pathogens. 2021;10:633; DOI:10.3390/pathogens10060633.JanikENiemcewiczMPodogrockiMMajsterekIBijakMThe emerging concern and interest SARS-CoV-2 variants20211063310.3390/pathogens10060633822433834064143Open DOISearch in Google Scholar